Vascular Solutions to Present at the 25th Annual Piper Jaffray Health Care
MINNEAPOLIS, Nov. 26, 2013 (GLOBE NEWSWIRE) -- Vascular Solutions, Inc.
(Nasdaq:VASC) today announced that the Company is scheduled to present at the
25^th Annual Piper Jaffray Health Care Conference in New York City on
Wednesday, December 4^th at 12:00pm (EST).
Phil Nalbone, Vice President of Corporate Development for Vascular Solutions,
will deliver the Company's presentation.To hear the live audio webcast of the
Vascular Solutions' presentation, go to the investor relations page of the
Company's web site http://www.vasc.com and click on the "IR Conferences" icon
a few minutes prior to start time to download any necessary software.
About Piper Jaffray
Piper Jaffray is a leading investment bank and asset management firm serving
clients in the U.S. and internationally.A proven advisory team combines deep
product and sector expertise with ready access to global capital.Founded in
1895, the firm is headquartered in Minneapolis and has offices across the
United States and in London, Hong Kong and Zurich.For more information,
connect to www.piperjaffray.com.
About Vascular Solutions
Vascular Solutions, Inc. is an innovative medical device company that focuses
on developing unique clinical solutions for coronary and peripheral vascular
procedures. The company's product line consists of more than 75 products in
three categories: catheter products, hemostat products and vein
products.Vascular Solutions delivers its products to interventional
cardiologists, interventional radiologists, electrophysiologists, and vein
specialists through its direct U.S. sales force and international independent
The information in this press release contains forward-looking statements that
involve risks and uncertainties. Our actual results could differ materially
from those anticipated in these forward-looking statements. Important factors
that may cause such differences include those discussed in our Annual Report
on Form 10-K for the year ended December 31, 2012 and other recent filings
with the Securities and Exchange Commission. The risks and uncertainties
include, without limitation, risks associated with the need for adoption of
our new products, lack of sustained profitability, exposure to intellectual
property claims, significant variability in quarterly results, exposure to
possible product liability claims, the development of new products by others,
doing business in international markets, the availability of third party
reimbursement, and actions by the FDA.
For further information, connect to www.vasc.com.
CONTACT: James Hennen, CFO
Phillip Nalbone, VP Corp. Dev.
Vascular Solutions, Inc.
Press spacebar to pause and continue. Press esc to stop.